Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02064712 · ClinicalTrials.gov registry record · NA

Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates

A NA study of Infant, Newborn and Infant, Premature, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
226
Enrollment target
1
Study location

NCT02064712 is a NA study of Infant, Newborn and Infant, Premature that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 226 participants, below the 228,262-participant average among 14 other Infant, Newborn trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02064712, a NA study of Infant, Newborn and Infant, Premature, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
226 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine an optimal strategy to wean nasal continuous positive airway pressure (NCPAP) in preterm babies. The investigators hypothesize that babies that are taken off NCPAP at lower settings will need fewer total days on NCPAP than those babies taken off at higher settings.

Interventions

  • OTHER Low CPAP Wean
  • OTHER High CPAP Wean

Study Locations (1)

Texas

  • Parkland Memorial Hospital - Dallas

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2014-09
Est. Completion 2018-10
Phase NA

What the Registry Record Tells You About NCT02064712

The ClinicalTrials.gov registry entry for NCT02064712 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228,262-participant average among 14 other Infant, Newborn trials with a reported enrollment target (100% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Infant, Newborn appearing as the primary indexed condition, and to 2 interventions - of which Low CPAP Wean is the first listed.

NCT02064712 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02064712 about?

NCT02064712 is a clinical study titled "Determining an Optimal Weaning Method of Nasal Continuous Positive Airway Pressure in Preterm Neonates". The purpose of this study is to determine an optimal strategy to wean nasal continuous positive airway pressure (NCPAP) in preterm babies. The investigators hypothesize that babies that are taken off NCPAP at lower settings will need fewer total days on NCPAP than those babies taken off at higher se...

What is the current status of trial NCT02064712?

This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2014-09. Estimated completion is 2018-10.

What conditions does trial NCT02064712 study?

This clinical trial studies the following conditions: Infant, Newborn, Infant, Premature.

What interventions are being tested in trial NCT02064712?

The interventions under investigation include: Low CPAP Wean (OTHER), High CPAP Wean (OTHER).

Who is sponsoring clinical trial NCT02064712?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02064712 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant, Newborn

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.